poisar

Stocks · News reference

Faeth Therapeutics Appoints Zymeworks Executive Adam Schayowitz to Board of Directors

Fiscal.ai

Faeth Therapeutics has appointed Adam Schayowitz, Ph.D., MBA, the Executive Vice President and Head of Research and Development at Zymeworks, to its Board of Directors.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Zymeworks Inc. (ZYME)

    Filed: 2026-11-16 AccNo: 0001937653-26-000070 Size: 197 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits